Discovery & Development

Streamlined workflows help scientists plot a course for painless peptide mapping

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.

Why does the full potential of biosimilars remain untapped? Four experts weigh in.

Rare diseases aren’t the only field that can benefit from repurposing – the eye is also often overlooked.

Drug repurposing can benefit many areas of drug discovery – particularly rare diseases.

Caffeine isn’t just a catalyst to get you moving in the morning – it can also help create polymers for drug delivery.

New data protection regulations are coming.

Eva has some bad news for Gene in the latest edition of "Trials of a Medicine Maker."

Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions.

A review of FDA data suggests that women are now better represented in clinical trials.